Our Products

Miro3D wound matrix

Miro3D wound matrix

Designed for deep and tunneling wounds

MiroDerm biologic wound matrix

MiroDerm biologic wound matrix

Designed for management of advanced wounds

MiroFlex biologic matrix

MiroFlex biologic matrix

Designed for surgical soft tissue reinforcement

Perfusion Decellularization Technology

With Reprise’s proprietary perfusion decellularization, the main vasculature of the liver is cannulated and perfused with a mild solution through the native vessels. The result is a preserved collagen scaffold with vasculature that retains strength and a micro-environment for cellular integration.


SAWC Spring – April 26-30

See us in April at the Symposium on Advanced Wound Care (SAWC) Spring Meeting, the largest gathering of multidisciplinary wound care clinicians in the United States.
Conference Website >


Reprise Biomedical’s Miro3D® Wound Matrix Granted Level II HCPCS Code by CMS

Read more here >

Customer Resources

Find reimbursement and ordering information here


Our Company

Reprise Biomedical is led by an experienced medical device management team with a record of success in commercializing biologic medical devices.

SM-00140 Rev. E 08/22